In May 2018 Sensius established an Advisory Board with board members with specific knowledge and experience on financing of startups, marketing and sales and a large global network within the field of oncology. Therefore, we are very happy to announce that Michel Rudolphie and Reender Beks, people with a strong connection to the working fields of Sensius, have accepted being a member or our Board of Advice.
Watch the short introduction to thermotherapy for head and neck cancer and Sensius
500 000 New patients worldwide get diagnosed with head and neck cancer annually. Treatment is very challenging. International biological research has proven that thermal therapy attacks cancer cells. The HyperCollar3D, developed by Erasmus MC, steers the heat to the tumor while avoiding sensitive organs. This therapy should be available worldwide - Sensius will deliver.